Other Species / Isoforms
  GYS1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T6-p
__MPLNRtLsMssLP
0 1
GYS1 (human) __MPLNRtLsMssLP T6-p
GYS1 iso2 (human) __MPLNRTLSMSSLP T6
GYS1 (mouse) __MPLSRSLsVssLP S6
GYS1 (rat) __MPLSRSLsMSsLP S6
GYS1 (rabbit) __MPLSRTLsVSsLP T6
S8-p
MPLNRtLsMssLPGL
Upstream
Downstream
15 1
Effects on Modified Protein
  • enzymatic activity, inhibited
Treatment
  • exercise
  • exercise training
  • insulin
  • racepinefrine
  • rest after exercise
GYS1 (human) MPLNRtLsMssLPGL S8-p
GYS1 iso2 (human) MPLNRTLSMSSLPGL S8
GYS1 (mouse) MPLSRSLsVssLPGL S8-p
GYS1 (rat) MPLSRSLsMSsLPGL S8-p
GYS1 (rabbit) MPLSRTLsVSsLPGL S8-p
S10-p
LNRtLsMssLPGLED
Upstream
1 1
Treatment
  • exercise
GYS1 (human) LNRtLsMssLPGLED S10-p
GYS1 iso2 (human) LNRTLSMSSLPGLED S10
GYS1 (mouse) LSRSLsVssLPGLED S10-p
GYS1 (rat) LSRSLsMSsLPGLED S10
GYS1 (rabbit) LSRTLsVSsLPGLED S10
S11-p
NRtLsMssLPGLEDW
Upstream
Downstream
9 3
Effects on Modified Protein
  • enzymatic activity, inhibited
Treatment
  • exercise
  • exercise training
  • insulin
  • rest after exercise
GYS1 (human) NRtLsMssLPGLEDW S11-p
GYS1 iso2 (human) NRTLSMSSLPGLEDW S11
GYS1 (mouse) SRSLsVssLPGLEDW S11-p
GYS1 (rat) SRSLsMSsLPGLEDW S11-p
GYS1 (rabbit) SRTLsVSsLPGLEDW S11-p
Y44-p
ANKVGGIyTVLQTKA
0 28
GYS1 (human) ANKVGGIyTVLQTKA Y44-p
GYS1 iso2 (human) ANKVGGIYTVLQTKA Y44
GYS1 (mouse) ANKVGGIyTVLQTKA Y44-p
GYS1 (rat) ANKVGGIyTVLQTKA Y44-p
GYS1 (rabbit) ANKVGGIYTVLQTKA Y44
K52-ub
TVLQTKAkVTGDEWG
0 4
GYS1 (human) TVLQTKAkVTGDEWG K52-ub
GYS1 iso2 (human) TVLQTKAKVTGDEWG K52
GYS1 (mouse) TVLQTKAKVTGDEWG K52
GYS1 (rat) TVLQTKAKVTGDEWG K52
GYS1 (rabbit) TVLQTKAKVTGDEWG K52
T75-p
YTEQGVRtQVELLEA
0 1
GYS1 (human) YTEQGVRtQVELLEA T75-p
GYS1 iso2 (human) YTEQGVRTQVELLEA T75
GYS1 (mouse) YTEQGVRTQVELLEP T75
GYS1 (rat) YTEQGVRTQVELLEP T75
GYS1 (rabbit) YTEQGVRTQVELLEP T75
K88-ac
EAPTPALkRTLDSMN
0 2
GYS1 (human) EAPTPALkRTLDSMN K88-ac
GYS1 iso2 (human) EAPTPALKRTLDSMN K88
GYS1 (mouse) EPPTPELKRTLDSMN K88
GYS1 (rat) EPPTPELKRTLDSMN K88
GYS1 (rabbit) EPPTPALKRTLDSMN K88
K88-ub
EAPTPALkRTLDSMN
0 6
GYS1 (human) EAPTPALkRTLDSMN K88-ub
GYS1 iso2 (human) EAPTPALKRTLDSMN K88
GYS1 (mouse) EPPTPELKRTLDSMN K88
GYS1 (rat) EPPTPELKRTLDSMN K88
GYS1 (rabbit) EPPTPALKRTLDSMN K88
K97-ac
TLDSMNSkGCkVyFG
0 1
GYS1 (human) TLDSMNSkGCkVyFG K97-ac
GYS1 iso2 (human) TLDSMNSKGCKFLAQ K97
GYS1 (mouse) TLDSMNSKGCKVYFG K97
GYS1 (rat) TLDSMNSKGCKVYFG K97
GYS1 (rabbit) TLDSMNSKGCKVYFG K97
K97-ub
TLDSMNSkGCkVyFG
0 3
GYS1 (human) TLDSMNSkGCkVyFG K97-ub
GYS1 iso2 (human) TLDSMNSKGCKFLAQ K97
GYS1 (mouse) TLDSMNSKGCKVYFG K97
GYS1 (rat) TLDSMNSKGCKVYFG K97
GYS1 (rabbit) TLDSMNSKGCKVYFG K97
K100-ac
SMNSkGCkVyFGRWL
0 1
GYS1 (human) SMNSkGCkVyFGRWL K100-ac
GYS1 iso2 (human) SMNSKGCKFLAQSEE K100
GYS1 (mouse) SMNSKGCKVYFGRWL K100
GYS1 (rat) SMNSKGCKVYFGRWL K100
GYS1 (rabbit) SMNSKGCKVYFGRWL K100
Y102-p
NSkGCkVyFGRWLIE
0 12
GYS1 (human) NSkGCkVyFGRWLIE Y102-p
GYS1 iso2 (human) gap -
GYS1 (mouse) NSKGCKVYFGRWLIE Y102
GYS1 (rat) NSKGCKVYFGRWLIE Y102
GYS1 (rabbit) NSKGCKVYFGRWLIE Y102
Y212
HATLLGRYLCAGAVD
0 5
GYS1 (human) HATLLGRYLCAGAVD Y212
GYS1 iso2 (human) HATLLGRYLCAGAVD Y148
GYS1 (mouse) HATLLGRYLCAGAVD Y212
GYS1 (rat) HATLLGRyLCAGAVD Y212-p
GYS1 (rabbit) HATLLGRYLCAGAVD Y212
K231-ub
LENFNVDkEAGERQI
0 1
GYS1 (human) LENFNVDkEAGERQI K231-ub
GYS1 iso2 (human) LENFNVDKEAGERQI K167
GYS1 (mouse) LENFNVDKEAGERQI K231
GYS1 (rat) LENFNVDKEAGERQI K231
GYS1 (rabbit) LENFNVDKEAGERQI K231
K271-ub
IEAQHLLkRkPDIVT
0 1
GYS1 (human) IEAQHLLkRkPDIVT K271-ub
GYS1 iso2 (human) IEAQHLLKRKPDIVT K207
GYS1 (mouse) IEAQHLLKRKPDIVT K271
GYS1 (rat) IEAQHLLKRKPDIVT K271
GYS1 (rabbit) IEAQHLLKRKPDIVT K271
K273-ub
AQHLLkRkPDIVTPN
0 2
GYS1 (human) AQHLLkRkPDIVTPN K273-ub
GYS1 iso2 (human) AQHLLKRKPDIVTPN K209
GYS1 (mouse) AQHLLKRKPDIVTPN K273
GYS1 (rat) AQHLLKRKPDIVTPN K273
GYS1 (rabbit) AQHLLKRKPDIVTPN K273
K285-ub
TPNGLNVkkFSAMHE
0 1
GYS1 (human) TPNGLNVkkFSAMHE K285-ub
GYS1 iso2 (human) TPNGLNVKKFSAMHE K221
GYS1 (mouse) TPNGLNVKKFSAMHE K285
GYS1 (rat) TPNGLNVKkFSAMHE K285
GYS1 (rabbit) TPNGLNVKKFSAMHE K285
K286
PNGLNVkKFSAMHEF
0 1
GYS1 (human) PNGLNVkKFSAMHEF K286
GYS1 iso2 (human) PNGLNVKKFSAMHEF K222
GYS1 (mouse) PNGLNVKKFSAMHEF K286
GYS1 (rat) PNGLNVKkFSAMHEF K286-ac
GYS1 (rabbit) PNGLNVKKFSAMHEF K286
K286-ub
PNGLNVkkFSAMHEF
0 2
GYS1 (human) PNGLNVkkFSAMHEF K286-ub
GYS1 iso2 (human) PNGLNVKKFSAMHEF K222
GYS1 (mouse) PNGLNVKKFSAMHEF K286
GYS1 (rat) PNGLNVKKFSAMHEF K286
GYS1 (rabbit) PNGLNVKKFSAMHEF K286
K301-ub
QNLHAQSkARIQEFV
0 1
GYS1 (human) QNLHAQSkARIQEFV K301-ub
GYS1 iso2 (human) QNLHAQSKARIQEFV K237
GYS1 (mouse) QNLHAQSKARIQEFV K301
GYS1 (rat) QNLHAQSKARIQEFV K301
GYS1 (rabbit) QNLHAQSKARIQEFV K301
K381-ub
NFNVETLkGQAVRkQ
Upstream
0 7
Treatment
  • MG132
GYS1 (human) NFNVETLkGQAVRkQ K381-ub
GYS1 iso2 (human) NFNVETLKGQAVRKQ K317
GYS1 (mouse) NFNVETLkGQAVRKQ K381-ub
GYS1 (rat) NFNVETLKGQAVRKQ K381
GYS1 (rabbit) NFNVETLKGQAVRKQ K381
K387-ub
LkGQAVRkQLWDTAN
0 2
GYS1 (human) LkGQAVRkQLWDTAN K387-ub
GYS1 iso2 (human) LKGQAVRKQLWDTAN K323
GYS1 (mouse) LkGQAVRKQLWDTAN K387
GYS1 (rat) LKGQAVRKQLWDTAN K387
GYS1 (rabbit) LKGQAVRKQLWDTAN K387
K397-ub
WDTANTVkEKFGRkL
0 4
GYS1 (human) WDTANTVkEKFGRkL K397-ub
GYS1 iso2 (human) WDTANTVKEKFGRKL K333
GYS1 (mouse) WDTANTVKEKFGRKL K397
GYS1 (rat) WDTANTVKEKFGRKL K397
GYS1 (rabbit) WDTANTVKEKFGRKL K397
K403-ub
VkEKFGRkLyESLLV
0 3
GYS1 (human) VkEKFGRkLyESLLV K403-ub
GYS1 iso2 (human) VKEKFGRKLYESLLV K339
GYS1 (mouse) VKEKFGRKLyESLLV K403
GYS1 (rat) VKEKFGRKLYESLLV K403
GYS1 (rabbit) VKEKFGRKLYESLLV K403
Y405-p
EKFGRkLyESLLVGs
0 10
GYS1 (human) EKFGRkLyESLLVGs Y405-p
GYS1 iso2 (human) EKFGRKLYESLLVGS Y341
GYS1 (mouse) EKFGRKLyESLLVGs Y405-p
GYS1 (rat) EKFGRKLYESLLVGs Y405
GYS1 (rabbit) EKFGRKLYESLLVGS Y405
S412-p
yESLLVGsLPDMNkM
0 17
GYS1 (human) yESLLVGsLPDMNkM S412-p
GYS1 iso2 (human) YESLLVGSLPDMNKM S348
GYS1 (mouse) yESLLVGsLPDMNKM S412-p
GYS1 (rat) YESLLVGsLPDMNKM S412-p
GYS1 (rabbit) YESLLVGSLPDMNKM S412
K418-ub
GsLPDMNkMLDkEDF
0 1
GYS1 (human) GsLPDMNkMLDkEDF K418-ub
GYS1 iso2 (human) GSLPDMNKMLDKEDF K354
GYS1 (mouse) GsLPDMNKMLDKEDF K418
GYS1 (rat) GsLPDMNKMLDKEDF K418
GYS1 (rabbit) GSLPDMNKMLDKEDF K418
K422-ub
DMNkMLDkEDFtMMk
0 1
GYS1 (human) DMNkMLDkEDFtMMk K422-ub
GYS1 iso2 (human) DMNKMLDKEDFTMMK K358
GYS1 (mouse) DMNKMLDKEDFTMMK K422
GYS1 (rat) DMNKMLDKEDFTMMk K422
GYS1 (rabbit) DMNKMLDKEDFTMMK K422
T426-p
MLDkEDFtMMkRAIF
0 1
GYS1 (human) MLDkEDFtMMkRAIF T426-p
GYS1 iso2 (human) MLDKEDFTMMKRAIF T362
GYS1 (mouse) MLDKEDFTMMKRAIF T426
GYS1 (rat) MLDKEDFTMMkRAIF T426
GYS1 (rabbit) MLDKEDFTMMKRAIF T426
K429
kEDFtMMKRAIFATQ
0 1
GYS1 (human) kEDFtMMKRAIFATQ K429
GYS1 iso2 (human) KEDFTMMKRAIFATQ K365
GYS1 (mouse) KEDFTMMKRAIFATQ K429
GYS1 (rat) KEDFTMMkRAIFATQ K429-ac
GYS1 (rabbit) KEDFTMMKRAIFATQ K429
K429-ub
kEDFtMMkRAIFATQ
0 1
GYS1 (human) kEDFtMMkRAIFATQ K429-ub
GYS1 iso2 (human) KEDFTMMKRAIFATQ K365
GYS1 (mouse) KEDFTMMKRAIFATQ K429
GYS1 (rat) KEDFTMMKRAIFATQ K429
GYS1 (rabbit) KEDFTMMKRAIFATQ K429
S439
IFATQRQSFPPVCTH
0 1
GYS1 (human) IFATQRQSFPPVCTH S439
GYS1 iso2 (human) IFATQRQSFPPVCTH S375
GYS1 (mouse) IFATQRQsFPPVCTH S439-p
GYS1 (rat) IFATQRQSFPPVCTH S439
GYS1 (rabbit) IFATQRQSFPPVCTH S439
S484-p
FHPEFLSstsPLLPV
0 1
GYS1 (human) FHPEFLSstsPLLPV S484-p
GYS1 iso2 (human) FHPEFLSSTSPLLPV S420
GYS1 (mouse) FHPEFLSSTSPLLPV S484
GYS1 (rat) FHPEFLSSTSPLLPV S484
GYS1 (rabbit) FHPEFLSSTSPLLPV S484
T485-p
HPEFLSstsPLLPVD
0 1
GYS1 (human) HPEFLSstsPLLPVD T485-p
GYS1 iso2 (human) HPEFLSSTSPLLPVD T421
GYS1 (mouse) HPEFLSSTSPLLPVD T485
GYS1 (rat) HPEFLSSTSPLLPVD T485
GYS1 (rabbit) HPEFLSSTSPLLPVD T485
S486-p
PEFLSstsPLLPVDY
0 1
GYS1 (human) PEFLSstsPLLPVDY S486-p
GYS1 iso2 (human) PEFLSSTSPLLPVDY S422
GYS1 (mouse) PEFLSSTSPLLPVDY S486
GYS1 (rat) PEFLSSTSPLLPVDY S486
GYS1 (rabbit) PEFLSSTSPLLPVDY S486
K599-ub
LSDLLDWkYLGRyYM
Upstream
0 6
Treatment
  • MG132
GYS1 (human) LSDLLDWkYLGRyYM K599-ub
GYS1 iso2 (human) LSDLLDWKYLGRYYM K535
GYS1 (mouse) LSDLLDWkYLGRYYM K599-ub
GYS1 (rat) LSDLLDWKYLGRYYM K599
GYS1 (rabbit) LSDLLDWKYLGRYYM K599
Y604-p
DWkYLGRyYMSARHM
0 1
GYS1 (human) DWkYLGRyYMSARHM Y604-p
GYS1 iso2 (human) DWKYLGRYYMSARHM Y540
GYS1 (mouse) DWkYLGRYYMSARHM Y604
GYS1 (rat) DWKYLGRYYMSARHM Y604
GYS1 (rabbit) DWKYLGRYYMSARHM Y604
K615-ub
ARHMALSkAFPEHFT
0 1
GYS1 (human) ARHMALSkAFPEHFT K615-ub
GYS1 iso2 (human) ARHMALSKAFPEHFT K551
GYS1 (mouse) ARHMALAKAFPDHFT K615
GYS1 (rat) ARHMALAKAFPDHFT K615
GYS1 (rabbit) ARHMALAKAFPDHFT K615
Y636-p
DAAQGYRyPRPAsVP
0 3
GYS1 (human) DAAQGYRyPRPAsVP Y636-p
GYS1 iso2 (human) DAAQGYRYPRPASVP Y572
GYS1 (mouse) DATQGYRyPRPAsVP Y636-p
GYS1 (rat) DATQGYRYPRPAsVP Y636
GYS1 (rabbit) DATQGYRYPRPAsVP Y636
S641-p
YRyPRPAsVPPsPsL
Upstream
Downstream
31 30
GYS1 (human)
S641-p
GYS1 (mouse)
S641-p
GYS1 (rat)
S641-p
Effects on Modified Protein
  • activity, inhibited
  • enzymatic activity, inhibited
Effects on Biological Processes:
  • signaling pathway regulation
Regulatory protein:
  • GSK3A (human)
  • MSTN (human)
  • PPP1R3F (human)
Treatment
  • acadesine
  • adenosine
  • exercise
  • exercise training
  • fasting
  • GH
  • glucose_starvation
  • insulin
  • LPS
  • norepinephrine
  • racepinefrine
  • rapamycin
  • rest after exercise
  • thapsigargin
  • tunicamycin
GYS1 (human) YRyPRPAsVPPsPsL S641-p
GYS1 iso2 (human) YRYPRPASVPPSPSL S577
GYS1 (mouse) YRyPRPAsVPPsPsL S641-p
GYS1 (rat) YRYPRPAsVPPsPSL S641-p
GYS1 (rabbit) YRYPRPAsVPPsPSL S641-p
S645-p
RPAsVPPsPsLsRHs
Upstream
Downstream
21 39
Effects on Modified Protein
  • activity, inhibited
  • enzymatic activity, inhibited
Effects on Biological Processes:
  • signaling pathway regulation
Kinase, in vitro:
  • GSK3B (human)
  • P38B (human)
Regulatory protein:
  • MSTN (human)
  • PPP1R3F (human)
Treatment
  • adenosine
  • exercise
  • glucose_starvation
  • insulin
  • norepinephrine
  • osmotic_stress
  • racepinefrine
  • rest after exercise
  • SB203580
GYS1 (human) RPAsVPPsPsLsRHs S645-p
GYS1 iso2 (human) RPASVPPSPSLSRHS S581
GYS1 (mouse) RPAsVPPsPsLsRHs S645-p
GYS1 (rat) RPAsVPPsPSLsRHs S645-p
GYS1 (rabbit) RPAsVPPsPSLsRHS S645-p
S647-p
AsVPPsPsLsRHssP
Upstream
0 10
Treatment
  • selumetinib
GYS1 (human) AsVPPsPsLsRHssP S647-p
GYS1 iso2 (human) ASVPPSPSLSRHSSP S583
GYS1 (mouse) AsVPPsPsLsRHssP S647-p
GYS1 (rat) AsVPPsPSLsRHssP S647
GYS1 (rabbit) AsVPPsPSLsRHSsP S647
S649-p
VPPsPsLsRHssPHQ
Upstream
Downstream
14 16
Effects on Modified Protein
  • activity, inhibited
Treatment
  • exercise
  • insulin
  • racepinefrine
GYS1 (human) VPPsPsLsRHssPHQ S649-p
GYS1 iso2 (human) VPPSPSLSRHSSPHQ S585
GYS1 (mouse) VPPsPsLsRHssPHQ S649-p
GYS1 (rat) VPPsPSLsRHssPHQ S649-p
GYS1 (rabbit) VPPsPSLsRHSsPHQ S649-p
S652-p
sPsLsRHssPHQsED
0 15
GYS1 (human) sPsLsRHssPHQsED S652-p
GYS1 iso2 (human) SPSLSRHSSPHQSED S588
GYS1 (mouse) sPsLsRHssPHQsED S652-p
GYS1 (rat) sPSLsRHssPHQsED S652-p
GYS1 (rabbit) sPSLsRHSsPHQsED S652
S653-p
PsLsRHssPHQsEDE
Upstream
Downstream
13 27
Effects on Modified Protein
  • activity, inhibited
Kinase, in vitro:
  • GSK3B (human)
  • P38B (human)
Treatment
  • dasatinib
  • exercise
  • insulin
  • racepinefrine
GYS1 (human) PsLsRHssPHQsEDE S653-p
GYS1 iso2 (human) PSLSRHSSPHQSEDE S589
GYS1 (mouse) PsLsRHssPHQsEDE S653-p
GYS1 (rat) PSLsRHssPHQsEDE S653-p
GYS1 (rabbit) PSLsRHSsPHQsEDE S653-p
S657-p
RHssPHQsEDEEDPR
Upstream
Downstream
14 50
Effects on Modified Protein
  • activity, inhibited
Treatment
  • dasatinib
  • exercise
  • insulin
  • racepinefrine
GYS1 (human) RHssPHQsEDEEDPR S657-p
GYS1 iso2 (human) RHSSPHQSEDEEDPR S593
GYS1 (mouse) RHssPHQsEDEEEPR S657-p
GYS1 (rat) RHssPHQsEDEEEPR S657-p
GYS1 (rabbit) RHSsPHQsEDEEEPR S657-p
G672
NGPLEEDGERyDEDE
0 7
GYS1 (human) NGPLEEDGERyDEDE G672
GYS1 iso2 (human) NGPLEEDGERYDEDE G608
GYS1 (mouse) DGPLGEDsERYDEEE S672-p
GYS1 (rat) DGPLREDsERYDEEE S672-p
GYS1 (rabbit) DGLPEEDGERYDEDE G672
Y675-p
LEEDGERyDEDEEAA
0 5
GYS1 (human) LEEDGERyDEDEEAA Y675-p
GYS1 iso2 (human) LEEDGERYDEDEEAA Y611
GYS1 (mouse) LGEDsERYDEEEEAA Y675
GYS1 (rat) LREDsERYDEEEEAA Y675
GYS1 (rabbit) PEEDGERYDEDEEAA Y675
K683-ub
DEDEEAAkDRRNIRA
0 2
GYS1 (human) DEDEEAAkDRRNIRA K683-ub
GYS1 iso2 (human) DEDEEAAKDRRNIRA K619
GYS1 (mouse) DEEEEAAkDRRNIRA K683-ub
GYS1 (rat) DEEEEAAKDRRNIRA K683
GYS1 (rabbit) DEDEEAAKDRRNIRA K683
S698-p
PEWPRRAsCtSSTSG
Upstream
1 14
Treatment
  • exercise
  • rest after exercise
GYS1 (human) PEWPRRAsCtSSTSG S698-p
GYS1 iso2 (human) PEWPRRASCTSSTSG S634
GYS1 (mouse) PEWPRRAsCSsSTGG S698-p
GYS1 (rat) PEWPRRASCSSSTGG S698
GYS1 (rabbit) PEWPRRASCTSSSGG S698
T700-p
WPRRAsCtSSTSGSK
0 1
GYS1 (human) WPRRAsCtSSTSGSK T700-p
GYS1 iso2 (human) WPRRASCTSSTSGSK T636
GYS1 (mouse) WPRRAsCSsSTGGSK S700
GYS1 (rat) WPRRASCSSSTGGSK S700
GYS1 (rabbit) WPRRASCTSSSGGSK T700
S701
PRRAsCtSSTSGSKR
0 1
GYS1 (human) PRRAsCtSSTSGSKR S701
GYS1 iso2 (human) PRRASCTSSTSGSKR S637
GYS1 (mouse) PRRAsCSsSTGGSKR S701-p
GYS1 (rat) PRRASCSSSTGGSKR S701
GYS1 (rabbit) PRRASCTSSSGGSKR S701
-
gap
0 2
GYS1 (human) gap -
GYS1 iso2 (human) gap -
GYS1 (mouse) STGGSKRsNsVDtGP S709-p
GYS1 (rat) STGGSKRSNsVDTGP S709
GYS1 (rabbit) SSGGSKRSNsVDTSS S709
S710-p
TSGSKRNsVDtAtss
Upstream
2 15
Treatment
  • exercise
  • rest after exercise
GYS1 (human) TSGSKRNsVDtAtss S710-p
GYS1 iso2 (human) TSGSKRNSVDTATSS S646
GYS1 (mouse) GGSKRsNsVDtGPSs S711-p
GYS1 (rat) GGSKRSNsVDTGPSS S711-p
GYS1 (rabbit) GGSKRSNsVDTSSLS S711-p
T713-p
SKRNsVDtAtsssLS
0 2
GYS1 (human) SKRNsVDtAtsssLS T713-p
GYS1 iso2 (human) SKRNSVDTATSSSLS T649
GYS1 (mouse) KRsNsVDtGPSsSLs T714-p
GYS1 (rat) KRSNsVDTGPSSSLS T714
GYS1 (rabbit) KRSNsVDTSSLSTPS T714
T715-p
RNsVDtAtsssLStP
0 1
GYS1 (human) RNsVDtAtsssLStP T715-p
GYS1 iso2 (human) RNSVDTATSSSLSTP T651
GYS1 (mouse) sNsVDtGPSsSLstP P716
GYS1 (rat) SNsVDTGPSSSLStP P716
GYS1 (rabbit) gap -
S716-p
NsVDtAtsssLStPs
0 2
GYS1 (human) NsVDtAtsssLStPs S716-p
GYS1 iso2 (human) NSVDTATSSSLSTPS S652
GYS1 (mouse) NsVDtGPSsSLstPt S717
GYS1 (rat) NsVDTGPSSSLStPT S717
GYS1 (rabbit) gap -
S717-p
sVDtAtsssLStPsE
0 2
GYS1 (human) sVDtAtsssLStPsE S717-p
GYS1 iso2 (human) SVDTATSSSLSTPSE S653
GYS1 (mouse) sVDtGPSsSLstPtE S718-p
GYS1 (rat) sVDTGPSSSLStPTE S718
GYS1 (rabbit) RSNsVDTSSLSTPSE S715
S718-p
VDtAtsssLStPsEP
0 1
GYS1 (human) VDtAtsssLStPsEP S718-p
GYS1 iso2 (human) VDTATSSSLSTPSEP S654
GYS1 (mouse) VDtGPSsSLstPtEP S719
GYS1 (rat) VDTGPSSSLStPTEP S719
GYS1 (rabbit) SNsVDTSSLSTPSEP S716
S720
tAtsssLStPsEPLs
0 1
GYS1 (human) tAtsssLStPsEPLs S720
GYS1 iso2 (human) TATSSSLSTPSEPLS S656
GYS1 (mouse) tGPSsSLstPtEPLs S721-p
GYS1 (rat) TGPSSSLStPTEPLs S721
GYS1 (rabbit) sVDTSSLSTPSEPLS S718
T721-p
AtsssLStPsEPLsP
Upstream
1 7
Kinase, in vitro:
  • P38B (human)
GYS1 (human) AtsssLStPsEPLsP T721-p
GYS1 iso2 (human) ATSSSLSTPSEPLSP T657
GYS1 (mouse) GPSsSLstPtEPLsP T722-p
GYS1 (rat) GPSSSLStPTEPLsP T722-p
GYS1 (rabbit) VDTSSLSTPSEPLSP T719
S723-p
sssLStPsEPLsPts
0 3
GYS1 (human) sssLStPsEPLsPts S723-p
GYS1 iso2 (human) SSSLSTPSEPLSPTS S659
GYS1 (mouse) SsSLstPtEPLsPts T724-p
GYS1 (rat) SSSLStPTEPLsPTS T724
GYS1 (rabbit) TSSLSTPSEPLSPAS S721
S727-p
StPsEPLsPtssLGE
Upstream
1 22
Kinase, in vitro:
  • P38B (human)
Treatment
  • anti-CD3
GYS1 (human) StPsEPLsPtssLGE S727-p
GYS1 iso2 (human) STPSEPLSPTSSLGE S663
GYS1 (mouse) stPtEPLsPtssLGE S728-p
GYS1 (rat) StPTEPLsPTSSLGE S728-p
GYS1 (rabbit) STPSEPLSPASSLGE S725
T729-p
PsEPLsPtssLGEER
0 3
GYS1 (human) PsEPLsPtssLGEER T729-p
GYS1 iso2 (human) PSEPLSPTSSLGEER T665
GYS1 (mouse) PtEPLsPtssLGEER T730-p
GYS1 (rat) PTEPLsPTSSLGEER T730
GYS1 (rabbit) PSEPLSPASSLGEER A727
S730-p
sEPLsPtssLGEERN
0 4
GYS1 (human) sEPLsPtssLGEERN S730-p
GYS1 iso2 (human) SEPLSPTSSLGEERN S666
GYS1 (mouse) tEPLsPtssLGEERN S731-p
GYS1 (rat) TEPLsPTSSLGEERN S731
GYS1 (rabbit) SEPLSPASSLGEERN S728
S731-p
EPLsPtssLGEERN_
Upstream
0 6
Treatment
  • anti-CD3
GYS1 (human) EPLsPtssLGEERN_ S731-p
GYS1 iso2 (human) EPLSPTSSLGEERN_ S667
GYS1 (mouse) EPLsPtssLGEERN_ S732-p
GYS1 (rat) EPLsPTSSLGEERN_ S732
GYS1 (rabbit) EPLSPASSLGEERN_ S729